Related Experiment Video

Updated: Jan 27, 2026

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

12.2K

[Vaccines for the treatment of non-small cell lung cancer]

C Leduc1, E Quoix1

  • 1Service de pneumologie, CHRU de Strasbourg, Strasbourg, France.

Revue Des Maladies Respiratoires
|March 24, 2019
PubMed

Insights

Antigen-specific immunotherapy, or cancer vaccination, offers a new treatment for non-small cell lung cancer by stimulating the immune system. This review details vaccine mechanisms and clinical study results for this promising approach.

Area of Science:

  • Oncology
  • Immunology
  • Vaccinology

Background:

  • Non-small cell lung cancer (NSCLC) remains a leading cause of cancer mortality.
  • Conventional treatments for NSCLC have limitations, necessitating novel therapeutic strategies.
  • Antigen-specific immunotherapy, or cancer vaccination, represents a promising alternative treatment modality.

Purpose of the Study:

  • To review the mechanisms of action for various cancer vaccines developed for NSCLC.
  • To summarize the clinical study outcomes of these antigen-specific immunotherapies.
  • To provide an overview of the current landscape of cancer vaccination in NSCLC treatment.

Main Methods:

  • Literature review of preclinical and clinical studies on cancer vaccines for NSCLC.
  • Analysis of different vaccine platforms including whole-tumor cells, dendritic cells, peptides, recombinant proteins, and viral vectors.
  • Evaluation of immune response induction and clinical efficacy data from published trials.

Main Results:

  • Various vaccine platforms have been explored for NSCLC, targeting specific tumor antigens.
  • These vaccines aim to prime or enhance adaptive antitumor immune responses.
  • Clinical studies have shown variable results, highlighting the need for further optimization and research.

Conclusions:

  • Antigen-specific immunotherapy holds potential as a treatment for NSCLC.
  • Understanding vaccine mechanisms and clinical data is crucial for advancing this field.
  • Further research is warranted to improve the efficacy of cancer vaccines in NSCLC patients.
Keywords:
CBNPCCancer bronchiqueCancer vaccinesImmunotherapyImmunothérapieLung cancerNSCLCVaccins

More Related Videos

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

378
Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines09:45

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines

Published on: August 21, 2019

7.5K

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
994
Vaccinations01:51

Vaccinations

Overview
51.3K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Lung Capacity01:47

Lung Capacity

The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.2K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.2K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.0K